CELC
Celcuity Inc.Company Information
- Company Name
- Celcuity Inc.
- CIK
- CIK0001603454
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CELC: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 08 Industrial Applications and Services
- SIC
- 8071
- SIC Description
- Services-Medical Laboratories
- Ticker
- CELC
SEC filing data through
Insider Sentiment
- Last purchase
- 2025-09-08
- Last sale
- 2026-05-04
- Shares purchased (TTM)
- 170,100
- Shares sold (TTM)
- 89,325
Institutional Sentiment
- As of
- 2026-03-31
- Institutional shares owned
- 47,178,014
- Shares outstanding
- 54,462,826
- Ownership
- 86.62%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 10.51%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 182 | 145 | 166 | 74 | 46 | 16 | 23 | 13 | 30 | 31 | 31 | 26 | ||||||
| Short Term Investments | 572 | 242 | 276 | 381 | 122 | 189 | 213 | 251 | 253 | 146 | 150 | 108 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 776 | 409 | 466 | 475 | 183 | 218 | 245 | 272 | 292 | 188 | 191 | 142 | ||||||
| Other Prepaid Expense Current | 13 | 15 | 19 | - | - | - | 7 | - | - | - | - | - | ||||||
| Other Assets Current | 9 | 6 | 5 | 21 | 15 | 12 | 3 | 8 | 9 | 10 | 10 | 8 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | 50 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Operating Lease Right Of Use Asset | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Noncurrent | 1 | 1 | 0 | - | - | - | - | - | - | - | - | - | ||||||
| Assets | 828 | 410 | 467 | 476 | 184 | 218 | 245 | 273 | 293 | 188 | 191 | 142 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Accounts Payable Current | 8 | 10 | 6 | 11 | 11 | 10 | 9 | 9 | 6 | 5 | 5 | 6 | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 87 | 33 | 44 | 39 | 40 | 33 | 32 | 26 | 20 | 17 | 14 | 13 | ||||||
| Other Liabilities Current | 21 | 14 | 21 | - | - | - | 5 | - | - | - | - | - | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | - | - | - | 27 | 29 | 23 | 22 | 17 | 13 | 11 | 9 | 7 | ||||||
| Operating Lease Liability Noncurrent | 1 | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Convertible Debt Noncurrent | 753 | 196 | 195 | 195 | - | - | - | - | - | - | - | - | ||||||
| Long Term Notes Payable | - | 128 | 127 | 125 | 99 | 99 | 98 | 97 | 96 | 38 | 37 | 37 | ||||||
| Preferred Stock Value | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 841 | 357 | 366 | 359 | 139 | 131 | 130 | 123 | 116 | 54 | 51 | 49 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 568 | 555 | 549 | 515 | 398 | 395 | 387 | 385 | 382 | 315 | 300 | 234 | ||||||
| Stockholders Equity | -13 | 54 | 101 | 117 | 44 | 87 | 116 | 150 | 177 | 134 | 140 | 93 | ||||||
| Retained Earnings Accumulated Deficit | -581 | -502 | -449 | -398 | -354 | -309 | -272 | -235 | -205 | -182 | -160 | -141 | ||||||
| Liabilities And Stockholders Equity | 828 | 410 | 467 | 476 | 184 | 218 | 245 | 273 | 293 | 188 | 191 | 142 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 95 | 95 | 95 | 95 | 95 | 95 | 95 | 65 | 65 | 65 | 65 | 65 | ||||||
| Common Stock Shares Issued | 49 | 48 | 48 | 43 | 39 | 38 | 37 | 37 | 37 | 31 | 26 | 22 | ||||||
| Shares Outstanding | 49 | 48 | 48 | 43 | 39 | 38 | 37 | 37 | 37 | 31 | 26 | 22 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCelcuity Inc. (CELC) — SEC Financial Statements & Analysis
Celcuity Inc. (CELC) is a services-medical laboratories company, incorporated in DE. Celcuity Inc. trades on Nasdaq as: CELC. Celcuity Inc. (CELC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, Celcuity Inc. carries a market cap of $5.73B, a P/E ratio of -25.32x, a P/B ratio of -448.70x, an enterprise value of $6.31B, and an EV/EBITDA multiple of -30.25x. On profitability, it posts a Return on Equity (ROE) of -1433.70%, a Return on Assets (ROA) of -44.77%, and a Return on Invested Capital (ROIC) of -63.65%. Per share, it reports EPS of $-4.13, diluted EPS of $-4.13, free cash flow per share of $-3.51, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 52.30% year-over-year and EPS growth of 21.31% year-over-year. On the balance sheet, it maintains a current ratio of 8.93x, a quick ratio of 8.93x, working capital of $688.97M, a debt-to-equity ratio of -65.80x, a debt ratio of 1.02, an interest coverage ratio of -9.37x, free cash flow of $-192.16M (TTM), and net debt of $571.19M. Figures sourced from SEC EDGAR.
- Market Cap
- $5.73B
- P/E TTM
- -25.32x
- EPS TTM
- $-4.13
- P/B TTM
- -448.70x
- ROE TTM
- -1433.70%
- ROA TTM
- -44.77%
- Debt To Equity
- -65.80x
- Free Cash Flow TTM
- $-192.16M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Celcuity Inc. in?
Celcuity Inc. (CELC) operates in the Services-Medical Laboratories industry.
What exchange does CELC trade on?
Celcuity Inc. (CELC) trades on the Nasdaq.
Where is Celcuity Inc. incorporated?
Celcuity Inc. is incorporated in DE.
When was Celcuity Inc. (CELC)'s most recent SEC filing?
Celcuity Inc. (CELC)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is CELC's market cap?
Celcuity Inc. (CELC) has a market capitalization of $5.73B as of 2026-06-30.
What is CELC's EPS (earnings per share)?
Celcuity Inc. (CELC)'s trailing twelve month EPS is $-4.13 as of 2026-06-30.
What is CELC's ROE (return on equity)?
Celcuity Inc. (CELC)'s trailing twelve month Return on Equity (ROE) is -1433.70% as of 2026-06-30.
What is CELC's ROA (return on assets)?
Celcuity Inc. (CELC)'s trailing twelve month Return on Assets (ROA) is -44.77% as of 2026-06-30.
What is CELC's ROIC (return on invested capital)?
Celcuity Inc. (CELC)'s trailing twelve month Return on Invested Capital (ROIC) is -63.65% as of 2026-06-30.
What is CELC's EV/EBITDA?
Celcuity Inc. (CELC)'s trailing twelve month EV/EBITDA is -30.25x as of 2026-06-30.

